U.S. residents are increasingly using Bitcoin to purchase peptides, with Q1 2026 sales reaching $32 million—a 700% increase year-over-year.
There has been a notable rise in the use of cryptocurrency, particularly Bitcoin, for purchasing peptides among U.S. residents. In the first quarter of 2026, sales of these products reached $32 million, reflecting an astonishing 700% increase compared to the previous year, as reported by Bloomberg based on Chainalysis data.
Peptides are often marketed for their potential benefits in weight loss, muscle gain, and longevity. While some of these products are clinically approved and available in pharmacies like Walgreens and CVS, a significant portion of sales occurs online, often circumventing traditional regulations.
Many of these online products are shipped from foreign labs and do not require prescriptions or insurance, with some packages explicitly stating they are not meant for human consumption.
The Role of Cryptocurrency
Due to compliance issues, banks and payment networks generally refuse to work with peptide sellers, prompting some to exclusively accept Bitcoin. Chainalysis notes that for many buyers, this represents their first encounter with cryptocurrency.
For instance, Zak, a 49-year-old marketing director from the Pacific Northwest, sought retatrutide from a Chinese supplier and ended up purchasing Bitcoin for the first time to complete a $240 transaction for 20 vials, a significantly lower price than the $300 he would have paid in the U.S.
Market Expansion
Chainalysis outlines three growth phases in this market. Initially, until 2025, it remained a niche underground market with monthly sales around $200,000. Increased attention from movements like Make America Healthy Again, correlated with Robert F. Kennedy Jr.'s appointment as head of the U.S. Department of Health, contributed to its expansion. However, a direct causal relationship cannot be conclusively drawn from blockchain data alone.
A notable surge occurred at the end of 2025 when the topic gained popularity within the TikTok community focused on looksmaxxing, leading to quadrupled monthly sales, averaging about $9.9 million, with peak months surpassing $10 million.
Sarah Graham, a former employee at Coinbase Global, estimated the peptide market's annual turnover to be around $100 million in 2023. TRM Labs reported that digital asset inflows into the sector hit $41.4 million in 2025, marking a 20% increase from the previous year. Eri Redbond, global policy director at the analytics firm, likened this trend to the early phases of shadow markets like Silk Road.
Stablecoin Adoption Among Major Sellers
The peptide market is characterized by an uneven structure. A small number of large suppliers dominate the market, handling most transactions more professionally. Larger sellers typically favor Bitcoin and stablecoins for transactions, especially those involving deposits over $1,000, to mitigate price volatility during significant purchases.
Supply Chain Dynamics
The primary raw materials for peptide production are sourced from China, where chemical manufacturers are expanding their footprint in this market. Reports indicate that U.S. imports from China doubled over the past year, exceeding $300 million.
Some suppliers have transitioned from the drug trade to focus on peptides, with companies like Bigreat Technology previously supplying precursors for fentanyl and amphetamines now establishing separate entities like Zhengzhou DEPU Technology for cosmetic peptides.
Additionally, analysts from Chainalysis noted a resurgence in the use of Bitcoin on darknet platforms in March 2026, indicating ongoing shifts in the market landscape.
